Last €39.76 EUR
Change Today -0.276 / -0.69%
Volume 0.0
As of 2:20 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

parexel international corp (PRXL) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/21/14 - €41.10
52 Week Low
12/5/13 - €28.27
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

parexel international corp (PRXL) Related Businessweek News

No Related Businessweek News Found

parexel international corp (PRXL) Details

PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PCMS segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, and good manufacturing practice compliance consulting; and market development, product development, commercialization, and targeted communications services in support of product launch. This segment’s consultants also identify alternatives and propose solutions to address clients’ product development, registration, and commercialization issues. The Perceptive segment offers information technology solutions comprising medical imaging and systems integration services, ClinPhone randomization and trial supply management services, regulatory information management solutions, clinical trial management systems, electronic data capture systems, Web-based portals, and patient diary applications. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham, Massachusetts.

14,700 Employees
Last Reported Date: 08/22/13
Founded in 1983

parexel international corp (PRXL) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $841.7K
President and Chief Operating Officer
Total Annual Compensation: $541.7K
Executive Vice President
Total Annual Compensation: $425.0K
Chief Administrative Officer and Senior Vice ...
Total Annual Compensation: $413.3K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $375.1K
Compensation as of Fiscal Year 2013.

parexel international corp (PRXL) Key Developments

PAREXEL International Corporation Reaffirms Earnings Guidance for the Fourth Quarter and Full Year Ending June 30, 2014; Provides Earnings Guidance for the Fiscal 2015

PAREXEL International Corporation reaffirmed earnings guidance for the fourth quarter and full year ending June 30, 2014. For the fourth quarter ending June 30, 2014, the company expects revenue of $507 million to $513 million compared to previous guidance range of $507 million to $513 million. GAAP Earnings per share (EPS) to be in the range of $0.59 to $0.63 compared to previous guidance range of $0.59 to $0.63. For the full year ending June 30, 2014, the company expects revenue of $1.936 billion to $1.942 billion compared to previous guidance range of $1.936 billion to $1.942 billion. GAAP Earnings per share (EPS) to be in the range of $2.13 to $2.17 compared to previous guidance range of $2.13 to $2.17. Non-GAAP earnings per share (EPS) to be in the range of $2.11 to $2.15 compared to previous guidance range of $2.11 to $2.15. The company expects net loss of $1,719,000 and income before income taxes of $1,966,000 and income from operations of $2,162,000. The company provided earnings guidance for the fiscal 2015. For the fiscal 2015, the company expects revenue of $2.120 billion to $2.150 billion and GAAP earnings per share (EPS) to be in the range of $2.51 to $2.75.

PAREXEL International Announces Launch of New Version of ClinPhone(R) RTSM Services

PAREXEL International announced the launch of a new version of its industry standard ClinPhone(R) RTSM services designed to help clients start clinical trials more quickly. Addressing issues, ClinPhone(R) RTSM can be more rapidly implemented using pre-built, interactive web modules for patient, supply and site activities common to every study. PAREXEL Informatics can also streamline system review and approval for clients via an efficient visual design approach. ClinPhone(R) RTSM is available through the Perceptive MyTrials(R) platform and as a standalone solution.

PAREXEL International Corporation - Analyst/Investor Day

To provide strategic overview of the company's businesses and discuss business developments through a series of presentations


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRXL:GR €39.76 EUR -0.276

PRXL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $53.63 USD +0.22
Covance Inc $86.62 USD +0.37
GFK SE €35.33 EUR -0.06
ICON PLC $47.72 USD -0.01
IMS Health Holdings Inc $26.88 USD +0.22
View Industry Companies

Industry Analysis


Industry Average

Valuation PRXL Industry Range
Price/Earnings 26.1x
Price/Sales 1.6x
Price/Book 4.6x
Price/Cash Flow 15.3x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAREXEL INTERNATIONAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at